First Affirmative Financial Network Dare Bioscience, Inc. Transaction History

First Affirmative Financial Network

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 Apr 11, 2024	BUY	$0.31 - $0.57 $345 - $634	1,114 Added 10.04%	12,211 $5,000
Q4 2023 Jan 08, 2024	BUY	$0.29 - $0.53 $3,218 - $5,881	11,097 New	11,097 $3,000

267K

Ticker DARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,820,896
Market Cap $271M
Description
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription pr...

Get notified when there are updates to the investment portfolio of First Affirmative Financial Network, based on Form 13F filings with the SEC.

Stay updated on First Affirmative Financial Network with notifications on news.